Future research in EMT aims to better understand the molecular mechanisms driving this process, identify novel biomarkers for early detection, and develop targeted therapies to inhibit EMT. Advances in single-cell sequencing and live-cell imaging are providing deeper insights into the dynamic nature of EMT and its role in cancer progression. Additionally, exploring the role of non-coding RNAs and epigenetic modifications in EMT regulation is an emerging area of interest.
